Composition
- Active ingredients
- LOPINAVIR 133.3MG; RITONAVIR 33.3MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LOPINAVIR 80MG/ML; RITONAVIR 20MG/ML · SolutionNDA021251-001 · Prescription
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletNDA021906-002 · Prescription
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletNDA021906-001 · Prescription
- LOPINAVIR 133.3MG; RITONAVIR 33.3MG · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021226.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Kaletra
- Active substance
- lopinavir
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 15 Sept 2000
- Application
- NDA021226-001